Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
REDWOOD CITY, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today announced that its third quarter 2026 financial results will be released on Monday, November 9, 2026. Starting at 5:00 p.m. Eastern Daylight Time on November 9, 2026, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
Covered in this story
Call it yourself
No calls on $CHRS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Coherus Oncology Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.